![]() |
CMRX | Chimerix Inc |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.35 |
Leverage | 14.43% |
Market Cap | $ 390.7m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -83.0m |
Margin | -50164.77% |
Chimerix, Inc., a developing-stage biopharmaceutical company, focuses on accelerating the advancement of various drugs that impact the lives of patients living with cancer and other serious diseases. The company is headquartered in Durham, North Carolina.